These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 21692115

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Erythropoietin in Friedreich ataxia: no effect on frataxin in a randomized controlled trial.
    Mariotti C, Fancellu R, Caldarazzo S, Nanetti L, Di Bella D, Plumari M, Lauria G, Cappellini MD, Duca L, Solari A, Taroni F.
    Mov Disord; 2012 Mar; 27(3):446-9. PubMed ID: 22411849
    [Abstract] [Full Text] [Related]

  • 3. Friedreich's ataxia: clinical pilot trial with recombinant human erythropoietin.
    Boesch S, Sturm B, Hering S, Goldenberg H, Poewe W, Scheiber-Mojdehkar B.
    Ann Neurol; 2007 Nov; 62(5):521-4. PubMed ID: 17702040
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits.
    Puccio H, Simon D, Cossée M, Criqui-Filipe P, Tiziano F, Melki J, Hindelang C, Matyas R, Rustin P, Koenig M.
    Nat Genet; 2001 Feb; 27(2):181-6. PubMed ID: 11175786
    [Abstract] [Full Text] [Related]

  • 7. Skeletal muscle involvement in friedreich ataxia and potential effects of recombinant human erythropoietin administration on muscle regeneration and neovascularization.
    Nachbauer W, Boesch S, Reindl M, Eigentler A, Hufler K, Poewe W, Löscher W, Wanschitz J.
    J Neuropathol Exp Neurol; 2012 Aug; 71(8):708-15. PubMed ID: 22805773
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Frataxin overexpressing mice.
    Miranda CJ, Santos MM, Ohshima K, Tessaro M, Sequeiros J, Pandolfo M.
    FEBS Lett; 2004 Aug 13; 572(1-3):281-8. PubMed ID: 15304363
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Safety and tolerability of carbamylated erythropoietin in Friedreich's ataxia.
    Boesch S, Nachbauer W, Mariotti C, Sacca F, Filla A, Klockgether T, Klopstock T, Schöls L, Jacobi H, Büchner B, vom Hagen JM, Nanetti L, Manicom K.
    Mov Disord; 2014 Jun 13; 29(7):935-9. PubMed ID: 24515352
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A high throughput electrochemiluminescence assay for the quantification of frataxin protein levels.
    Steinkellner H, Scheiber-Mojdehkar B, Goldenberg H, Sturm B.
    Anal Chim Acta; 2010 Feb 05; 659(1-2):129-32. PubMed ID: 20103114
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.